{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:36:17Z","timestamp":1779154577668,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,29]],"date-time":"2012-04-29T00:00:00Z","timestamp":1335657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s12098-012-0765-1","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T02:21:24Z","timestamp":1335579684000},"page":"1062-1068","source":"Crossref","is-referenced-by-count":36,"title":["Vitamin D in Chronic Kidney Disease"],"prefix":"10.1007","volume":"79","author":[{"given":"Yahn-Yir","family":"Chau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,29]]},"reference":[{"key":"765_CR1","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S\u201396S.","journal-title":"Am J Clin Nutr."},{"key":"765_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","volume":"92","author":"P Lips","year":"2006","unstructured":"Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4\u20138.","journal-title":"Prog Biophys Mol Biol."},{"key":"765_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med."},{"key":"765_CR4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jsbmb.2006.12.089","volume":"103","author":"AJ Brown","year":"2007","unstructured":"Brown AJ. Vitamin D analogs for secondary hyperparathyroidism: what does the future hold? J Steroid Biochem Mol Biol. 2007;103:578\u201383.","journal-title":"J Steroid Biochem Mol Biol."},{"key":"765_CR5","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1210\/jc.2002-021356","volume":"87","author":"P Correa","year":"2002","unstructured":"Correa P, Segersten U, Hellman P, Akerstrom G, Westin G. Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors\u2013new prospects for treatment of hyperparathyroidism with vitamin D. J Clin Endocrinol Metab. 2002;87:5826\u20139.","journal-title":"J Clin Endocrinol Metab."},{"key":"765_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","volume":"24","author":"EA Gonzalez","year":"2004","unstructured":"Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004;24:503\u201310.","journal-title":"Am J Nephrol."},{"key":"765_CR7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","volume":"20","author":"M Driel van","year":"2006","unstructured":"van Driel M, Koedam M, Buurman CJ, et al. Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J. 2006;20:2417\u20139.","journal-title":"FASEB J."},{"key":"765_CR8","first-page":"1","volume":"158","author":"A Cranney","year":"2007","unstructured":"Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess. 2007;158:1\u2013235.","journal-title":"Evid Rep Technol Assess."},{"key":"765_CR9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","volume":"29","author":"R Bouillon","year":"2008","unstructured":"Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726\u201376.","journal-title":"Endocr Rev."},{"key":"765_CR10","doi-asserted-by":"crossref","first-page":"491S","DOI":"10.3945\/ajcn.2008.27049","volume":"88","author":"AW Norman","year":"2008","unstructured":"Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:491S\u20139S.","journal-title":"Am J Clin Nutr."},{"key":"765_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","volume":"69","author":"DL Andress","year":"2006","unstructured":"Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006;69:33\u201343.","journal-title":"Kidney Int."},{"key":"765_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229\u201338.","journal-title":"J Clin Invest."},{"key":"765_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-139X.2005.18402.x","volume":"18","author":"MF Holick","year":"2005","unstructured":"Holick MF. Vitamin D for health and in chronic kidney disease. Semin Dial. 2005;18:266\u201375.","journal-title":"Semin Dial."},{"key":"765_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","volume":"94","author":"D Bikle","year":"2009","unstructured":"Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26\u201334.","journal-title":"J Clin Endocrinol Metab."},{"key":"765_CR15","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine","year":"2010","unstructured":"Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington: National Academy of Sciences; 2010."},{"key":"765_CR16","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ajcn\/87.6.1738","volume":"87","author":"RP Heaney","year":"2008","unstructured":"Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87:1738\u201342.","journal-title":"Am J Clin Nutr."},{"key":"765_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","volume":"338","author":"MK Thomas","year":"1998","unstructured":"Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777\u201383.","journal-title":"N Engl J Med."},{"key":"765_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.328","volume":"26","author":"RP Heaney","year":"2011","unstructured":"Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res. 2011;26:455\u20137.","journal-title":"J Bone Miner Res."},{"key":"765_CR19","doi-asserted-by":"crossref","unstructured":"K\/DOQI Workgroup. K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1-153.","DOI":"10.1053\/j.ajkd.2005.01.019"},{"key":"765_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00592-008-0071-6","volume":"46","author":"A Bener","year":"2009","unstructured":"Bener A, Alsaied A, Al-Ali M, et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009;46:183\u20139.","journal-title":"Acta Diabetol."},{"key":"765_CR21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-008-1041-5","volume":"24","author":"V Belostotsky","year":"2009","unstructured":"Belostotsky V, Mughal Z, Webb NJ. A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease. Pediatr Nephrol. 2009;24:625\u20136.","journal-title":"Pediatr Nephrol."},{"key":"765_CR22","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00467-010-1639-2","volume":"25","author":"P Hari","year":"2010","unstructured":"Hari P, Gupta N, Hari S, Gulati A, Mahajan P, Bagga A. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr Nephrol. 2010;25:2483\u20138.","journal-title":"Pediatr Nephrol."},{"key":"765_CR23","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00467-008-0842-x","volume":"23","author":"S Menon","year":"2008","unstructured":"Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol. 2008;23:1831\u20136.","journal-title":"Pediatr Nephrol."},{"key":"765_CR24","doi-asserted-by":"crossref","unstructured":"Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M. Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr.2009 ;154:906\u201311. e1.","DOI":"10.1016\/j.jpeds.2008.12.006"},{"key":"765_CR25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ki.2011.431","volume":"81","author":"HJ Kalkwarf","year":"2012","unstructured":"Kalkwarf HJ, Denburg MR, Strife CF, et al. Vitamin D deficiency is common in children and adolescents with chronic kidney disease. Kidney Int. 2012;81:690\u20137.","journal-title":"Kidney Int."},{"key":"765_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2215\/CJN.01310307","volume":"3","author":"DL Andress","year":"2008","unstructured":"Andress DL. Bone and mineral guidelines for patients with chronic kidney disease: a call for revision. Clin J Am Soc Nephrol. 2008;3:179\u201383.","journal-title":"Clin J Am Soc Nephrol."},{"key":"765_CR27","unstructured":"Hollis BW, Jacob Al, Sallman A, Santiz Z, Lambert PW. Circulating vitamin D and its photoproduction in uremia. In: Norman AW, Schaefer K, Herrath Dv, Grigoleit H,eds. Vitamin D, chemical, biochemical and clinical endocrinology of calcium metabolism. Berlin: Walter de Gruyter; 1982.pp.1157-61."},{"key":"765_CR28","first-page":"325","volume":"99","author":"KA Sato","year":"1982","unstructured":"Sato KA, Gray RW, Lemann Jr J. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med. 1982;99:325\u201330.","journal-title":"J Lab Clin Med."},{"key":"765_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31\u20138.","journal-title":"Kidney Int."},{"key":"765_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/325062a0","volume":"325","author":"MR Clements","year":"1987","unstructured":"Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature. 1987;325:62\u20135.","journal-title":"Nature."},{"key":"765_CR31","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205\u201315.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1210\/jcem-59-6-1063","volume":"59","author":"BP Halloran","year":"1984","unstructured":"Halloran BP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984;59:1063\u20139.","journal-title":"J Clin Endocrinol Metab."},{"key":"765_CR33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","volume":"96","author":"A Nykjaer","year":"1999","unstructured":"Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96:507\u201315.","journal-title":"Cell."},{"key":"765_CR34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000223800","volume":"163","author":"JM Valdivielso","year":"2009","unstructured":"Valdivielso JM. The physiology of vitamin D receptor activation. Contrib Nephrol. 2009;163:206\u201312.","journal-title":"Contrib Nephrol."},{"key":"765_CR35","unstructured":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl.2009;113:S1-130."},{"key":"765_CR36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, et al. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010;55:773\u201399.","journal-title":"Am J Kidney Dis."},{"key":"765_CR37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","volume":"93","author":"MF Holick","year":"2008","unstructured":"Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metabol. 2008;93:677\u201381.","journal-title":"J Clin Endocrinol Metabol."},{"key":"765_CR38","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2010-2230","volume":"96","author":"RP Heaney","year":"2011","unstructured":"Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metabol. 2011;96:E447\u201352.","journal-title":"J Clin Endocrinol Metabol."},{"key":"765_CR39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","volume":"7","author":"R Shroff","year":"2012","unstructured":"Shroff R, Wan M, Gullett A, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol. 2012;7:216\u201323.","journal-title":"Clin J Am Soc Nephrol."},{"key":"765_CR40","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1097\/01.ASN.0000101240.47747.7F","volume":"14","author":"CP Schmitt","year":"2003","unstructured":"Schmitt CP, Obry J, Feneberg R, et al. Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. J Am Soc Nephrol. 2003;14:3245\u201350.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR41","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1523-1755.2005.00339.x","volume":"67","author":"SC Waller","year":"2005","unstructured":"Waller SC, Ridout D, Cantor T, Rees L. Parathyroid hormone and growth in children with chronic renal failure. Kidney Int. 2005;67:2338\u201345.","journal-title":"Kidney Int."},{"key":"765_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","volume":"79","author":"K Wesseling-Perry","year":"2011","unstructured":"Wesseling-Perry K, Pereira RC, Sahney S, et al. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int. 2011;79:112\u20139.","journal-title":"Kidney Int."},{"key":"765_CR43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/j.ajkd.2007.03.008","volume":"49","author":"LA Greenbaum","year":"2007","unstructured":"Greenbaum LA, Benador N, Goldstein SL, et al. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis. 2007;49:814\u201323.","journal-title":"Am J Kidney Dis."},{"key":"765_CR44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00467-006-0204-5","volume":"21","author":"W Seeherunvong","year":"2006","unstructured":"Seeherunvong W, Nwobi O, Abitbol CL, Chandar J, Strauss J, Zilleruelo G. Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol. 2006;21:1434\u20139.","journal-title":"Pediatr Nephrol."},{"key":"765_CR45","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2007090993","volume":"19","author":"R Shroff","year":"2008","unstructured":"Shroff R, Egerton M, Bridel M, et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol. 2008;19:1239\u201346.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3476(82)80602-1","volume":"100","author":"CB Langman","year":"1982","unstructured":"Langman CB, Mazur AT, Baron R, Norman ME. 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr. 1982;100:815\u201320.","journal-title":"J Pediatr."},{"key":"765_CR47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM197802022980503","volume":"298","author":"RW Chesney","year":"1978","unstructured":"Chesney RW, Moorthy AV, Eisman JA, Jax DK, Mazess RB, DeLuca HF. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med. 1978;298:238\u201342.","journal-title":"N Engl J Med."},{"key":"765_CR48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(05)83128-2","volume":"124","author":"JC Chan","year":"1994","unstructured":"Chan JC, McEnery PT, Chinchilli VM, et al. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The growth failure in children with renal diseases investigators. J Pediatr. 1994;124:520\u20138.","journal-title":"J Pediatr."},{"key":"765_CR49","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","volume":"18","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi M, Morrissey J, Finch JL, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol. 2007;18:1796\u2013806.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","volume":"54","author":"S Fishbane","year":"2009","unstructured":"Fishbane S, Chittineni H, Packman M, Dutka P, Ali N, Durie N. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis. 2009;54:647\u201352.","journal-title":"Am J Kidney Dis."},{"key":"765_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","volume":"52","author":"P Alborzi","year":"2008","unstructured":"Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008;52:249\u201355.","journal-title":"Hypertension."},{"key":"765_CR52","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Acharya M, Tian J, et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005;68:2823\u20138.","journal-title":"Kidney Int."},{"key":"765_CR53","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D Zeeuw de","year":"2010","unstructured":"de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376:1543\u201351.","journal-title":"Lancet."},{"key":"765_CR54","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/MJT.0b013e3181d16999","volume":"17","author":"JF Feneis","year":"2010","unstructured":"Feneis JF, Arora RR. Role of vitamin D in blood pressure homeostasis. Am J Ther. 2010;17:e221\u20139.","journal-title":"Am J Ther."},{"key":"765_CR55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00869730","volume":"6","author":"RH Mak","year":"1992","unstructured":"Mak RH. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol. 1992;6:345\u20138.","journal-title":"Pediatr Nephrol."},{"key":"765_CR56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72:1004\u201313.","journal-title":"Kidney Int."},{"key":"765_CR57","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","volume":"168","author":"H Dobnig","year":"2008","unstructured":"Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340\u20139.","journal-title":"Arch Intern Med."},{"key":"765_CR58","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","volume":"20","author":"ML Melamed","year":"2009","unstructured":"Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009;20:2631\u20139.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","volume":"75","author":"P Ravani","year":"2009","unstructured":"Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75:88\u201395.","journal-title":"Kidney Int."},{"key":"765_CR60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","volume":"168","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008;168:397\u2013403.","journal-title":"Arch Intern Med."},{"key":"765_CR61","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1681\/ASN.2007091002","volume":"19","author":"M Wolf","year":"2008","unstructured":"Wolf M, Betancourt J, Chang Y, et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol. 2008;19:1379\u201388.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR62","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","volume":"16","author":"M Teng","year":"2005","unstructured":"Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005;16:1115\u201325.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR63","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008;19:1509\u201319.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR64","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","volume":"104","author":"N Bodyak","year":"2007","unstructured":"Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA. 2007;104:16810\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"765_CR65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00246-011-0101-y","volume":"33","author":"AR Patange","year":"2012","unstructured":"Patange AR, Valentini RP, Du W, Pettersen MD. Vitamin d deficiency and arterial wall stiffness in children with chronic kidney disease. Pediatr Cardiol. 2012;33:122\u20138.","journal-title":"Pediatr Cardiol."},{"key":"765_CR66","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","volume":"19","author":"X Tan","year":"2008","unstructured":"Tan X, Wen X, Liu Y. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol. 2008;19:1741\u201352.","journal-title":"J Am Soc Nephrol."},{"key":"765_CR67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ki.2009.346","volume":"76","author":"X Tan","year":"2009","unstructured":"Tan X, He W, Liu Y. Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney Int. 2009;76:1248\u201357.","journal-title":"Kidney Int."}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-012-0765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-012-0765-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-012-0765-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T21:44:37Z","timestamp":1561671877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-012-0765-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,29]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1007\/s12098-012-0765-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,29]]}}}